Correction to: In vitro evaluation of the anti-apoptotic drug Z-VAD-FMK on human ovarian granulosa cell lines for further use in ovarian tissue transplantation.

The errors occurred in Figure 2, specifically in panels G, H, and I of the published article. The errors were due to the splicing of Western blot images to align the presentation of the conditions with other figures in the paper (specifically with Fig 2 a-f), which could mislead or confuse the interpretation. Additionally, an important blot for p53 in panel H was omitted during the assembly of the figure for publication. Figure 2G: The entire panel will be replaced with an unspliced version of the Western blot. Figure 2H: This panel will be replaced with an unspliced version of the Western blot and will now include the previously omitted p53 negative data. Figure 2I: This panel will also be replaced with an unspliced version. (Figure presented.) Figure 2G: The entire panel will be replaced with an unspliced version of the Western blot. Figure 2H: This panel will be replaced with an unspliced version of the Western blot and will now include the previously omitted p53 negative data. Figure 2I: This panel will also be replaced with an unspliced version. We confirm that these changes do not affect the paper's overall results and conclusions. The corrected figures provide a more transparent and accurate visual representation of the data without altering the scientific conclusions derived from the original dataset. The integrity of the findings and their implications remain intact, as the experimental outcomes are consistently supported by the quantitative data and other figures within the publication. The original article has been corrected.